Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

1(25%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_4

50%

Ph phase_3

25%

Ph not_applicable

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 3Large-scale testing

1(25.0%)

Phase 4Post-market surveillance

2(50.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Other(1)

Detailed Status

Completed2

unknown1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 31 (25.0%)

Phase 42 (50.0%)

N/A1 (25.0%)

Trials by Status

completed250%

unknown125%

recruiting125%

Recent Activity

1 active trials

Showing 4 of 4

recruitingnot_applicable

Efficacy of Dexmedetomidine-Propofol Versus Ketamine-Propofol for Sedation

NCT06756594

completedphase_3

Sedation MRI - Propofol Versus Propofol-Ketamin in Children

NCT01519154

completedphase_4

Dexmedetomidine-Propofol Versus Ketamine-Propofol for Sedation of CT Guided Bone Biopsy

NCT05752903

unknownphase_4

Ketofol Versus Propofol in Urgent ERCP for Acute Cholangitis

NCT04997967

Clinical Trials (4)

Showing 4 of 4 trials

NCT06756594Not Applicable

Efficacy of Dexmedetomidine-Propofol Versus Ketamine-Propofol for Sedation

Recruiting

NCT01519154Phase 3

Sedation MRI - Propofol Versus Propofol-Ketamin in Children

Completed

NCT05752903Phase 4

Dexmedetomidine-Propofol Versus Ketamine-Propofol for Sedation of CT Guided Bone Biopsy

Completed

NCT04997967Phase 4

Ketofol Versus Propofol in Urgent ERCP for Acute Cholangitis

Unknown

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4